Nykode Therapeutics AS (VACBF)
OTCMKTS
· Delayed Price · Currency is USD
0.2749
0.00 (0.00%)
At close: Apr 23, 2025
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of $86.71 million as of May 9, 2025. Its market cap has decreased by -77.74% in one year.
Market Cap
86.71M
Enterprise Value
-36.02M
Revenue
9.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.27
Market Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 604.82M to 86.71M, a decrease of -85.66%. That is a compound annual growth rate of -30.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 86.71M | -0.85% |
| Dec 30, 2024 | 87.46M | -87.31% |
| Dec 29, 2023 | 689.14M | -18.07% |
| Dec 30, 2022 | 841.13M | -68.30% |
| Dec 30, 2021 | 2.65B | 6.21% |
| Dec 30, 2020 | 2.50B | 313.01% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.62B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 729.60M |
| Tian'an Technology Group | 568.98M |
| Glass House Brands | 484.30M |
| Elite Pharmaceuticals | 448.25M |
| CytoDyn | 401.33M |
| Northwest Biotherapeutics | 390.49M |